Topic Archives: Emerging Growth

I’m running out of time today, so you get a quickie: Louis Navellier’s latest “stealth buy” promo, solved for your pleasure… but without any real analysis from me. The ad is for Navellier’s Emerging Growth ($995/yr), and it pushes the possibilities of small caps and the particular appeal of one small “secret” $14 stock that […]

We haven’t looked at a Louis Navellier pitch for a little while, and this one caught the eye of some intrepid Gumshoe readers — it is, like virtually every Louis Navellier pitch, a promise that his favorite growth stock will double this year… though he goes even further in announcing that “long term, a $1,000 […]

This one has investors everywhere frothing at the mouth — or at least, that’s how it seems from this end of the email queries your friendly neighborhood Gumshoe is receiving about Louis Navellier’s favorite stock. So at the very least, the copywriters at Investorplace (Navellier’s publisher) are awfully good at catching your eye — they […]

Here’s how Louis Navellier pitches his next uber-hot idea for a stock that gives you three phone numbers on one phone and 10-bagger profits: “Last May I told you about a new wireless juggernaut whose 3-in-one proprietary technology and earnings growth matched Envirodyne, which handed us a monster 1,700% gain a few years back. “Since […]

In the few days preceding the last presidential debate between McCain and Obama (which was soooo boring … I was really hoping for more winking, personally), Louis Navellier continued his presidential-themed teaser ad campaigns. Last time around, he was promising that he had written the perfect campaign speech, and that whoever uttered it would be […]

Comments

  • Avatar

    Emails that went out Dated May 7. Both should be on the Akts Site. Akoustis Announces First Pre-Production Order for...

  • Avatar

    Motley Fool is a service that tips stocks to its high payers first, then trickles down to the medium payers and ordinary...

  • Avatar

    I have had the Navallier newsletter since the 90's. I subscribe to Investor Growth which was Blue Chip Growth until rec...

  • Avatar

    Hi Travis! You have taken my thinking about my investments to a whole new level, thank you so much for sharing your ex...

  • Avatar

    SEC charges Navellier & Associates with fraud The regulator said the Reno adviser's marketing materials misrepresen...

  • Avatar

    I have been a member through a deeply discounted offer for all 5 services for 5 yrs., as a family it’s quite affordabl...

  • Avatar

    Hello Amit this thread is no longer active . Go to the top of this page and click on Articles,then Articles by Author. ...

  • SoGiAm

    $ONOV, Hi MeadowBrookManor, We have moved on to the following thread: : https://www.stockgumshoe.com/2017/11/notes-f...

  • Dr. KSS MD PhD

    My apologies for being slow getting to this. One comes home jetlagged, sleep-deprived and to a tsunami of mail and bills...

  • arch1

    KSS, MD, PhD‏ @KSSMDPhD A mitochondrially-derived peptide owned by $CWBR recently shown to abate completely any tox...

  • SoGiAm

    “Notes from Torrey Hills Capital Emerging Growth Conference, 13-15 November 2017, San Diego, CA” https://www.stockg...

  • Dr. KSS MD PhD

    Good morning all: I will be pretty scarce here for the rest of today and tomorrow. Today I fly to San Diego for the Torr...

  • Avatar

    I'm a current emerging growth subscriber and ALB Albemarle is not currently on the buy list or current position in the ...

  • Avatar

    Excellent value for the investment advice given. The price is usually around $99 per year. I've been following for many...

  • Avatar

    Any ideas about the magnetic marvel being pitched by Navellier for Emerging Growth?...

  • SoGiAm

    $AKTX new position 4 HelenO - NEW YORK and LONDON, May 26, 2016 (GLOBE NEWSWIRE) -- Akari Therapeutics (AKTX), an emergi...

  • sogiam

    BBLG-Feb 29th: Bone Biologics Completes $5.75 Million Round Of Financing 10:15 am ET February 29, 2016(PR Newswire Bon...

  • Avatar

    Lewis has owned RGEN, LGND before not sure about SVA so for them to show up on his emerging growth when RGEN was a Blue...

  • Avatar

    Nope, not SNTS. That one got acquired and sold for 600%+ gains last year in Emerging Growth (I'm a current subscriber)....

  • Avatar

    RE: Your slanted comments on the (SNTS) stock recommended in the Navellier Emerging Growth letter should have indicat...

  • Avatar

    Thanks Travis.. you are the best!!! It's amazing !! He should have toted this back in Feb. or March when it was .80 and ...

  • Avatar

    I subscribed to Navellier's Emerging Growth Newsletter during the financial crisis in 2008. I lost so much money tradin...

  • Avatar

    Emerging Growth is nothing but a Pump and Dump. More than 30% of the "buys" are negative, some down 20 - 30 %....

  • Avatar

    A few years ago I subscribed to both Emerging Growth and Blue Chip at the same time. I compared their returns for the...

  • Avatar

    CAN YOU SOLVE THIS ONE? Fellow Investor: I just identified a little-known Apple parts supplier that will let you b...

  • Avatar

    Wouldn't be shocking if he was using something other than his newest focus stock and saying it's the hot new t...

  • Avatar

    I just read the August issue of Emerging Growth and there is no drug company in the issue. This must be another writer...

  • Avatar

    I subscribed to this service in Spring 2008 when Louie's pick did well for me. Obviously, a month's trial is hit or miss...

  • Avatar

    I started with Louis Navellier a decade ago and did well in a bull market with Emerging Growth & Blue Chip Growth. A...

  • Avatar

    Of the twelve stocks I have bought in the few months I have followed this service, nine have gained substantially, two ...

  • Avatar

    Navellier is a former computer programmer, who now uses his own program to pick stocks for his subscribers to his variou...

  • Avatar

    I subscribed to Emerging Growth for about one year, a few years ago. Navellier touts a huge return investing in these g...

  • Avatar

    Biotechs kinda scare me. I got my clocked cleaned in SQNM back in the bubble days but I know one thing. Navallier has ...

  • Avatar

    I forgot. Emerging Growth portfolio is now completely negative. Not a single winner in there. See details on investor...

  • Avatar

    The review I wrote for Emerging Growth in fact I meant to be for this Letter "Quantum Growth". The Letter is very pricey...

  • Avatar

    I've subscribed to Blue Chip on an off for the last several years, the first of which were in up market conditions. Gre...

  • Avatar

    I have subscribed to emerging growth for a couple of years now. This newsletter is on the pricey side, about 1k per yea...

  • Avatar

    Just FYI: Hulbert tracks Navellier's two less expensive newsletters (but not the $5,000 ones) -- of those, Blue Chip Gro...

  • Avatar

    Just found this site, very nice, wish I found it sooner. I subscribed to LN Blue Chip and Emerging Growth in late '07 b...

  • Avatar

    FYI I have been a subscriber, off and on, for over 5 years to the Blue Chip Growth and other newsletters from Phillips P...

  • Avatar

    Nope, not FLS. Earnings way too high, and company way too big. FLS has had a great run though. And it does do valves....

  • This site and Stock Gumshoe publications and authors do not offer individual financial, investment, medical or other advice. Nothing on this site should ever be considered to be personal advice, research or an invitation to buy or sell any securities. We also make mistakes and bad decisions sometimes, and our reasoning or data should be checked against trusted sources before they inform your investing decisions. Choices regarding how to invest your money or otherwise manage your life or finances are yours, we share only our analysis and opinion and all authors or commenters are individually responsible for the words and opinions they share here. Please read our important disclaimers and policies. Stock Gumshoe is supported by subscribers and by sponsors and advertisers. Stock Gumshoe's employee authors will disclose holdings in any stock covered at time of publication and will not trade in any stocks written about for at least three days after publication. Please see below for complete disclosure, disclaimer and policy information.

    Connect with Travis

    website designed by Gravity Switch